Associations between Socio-Demographic Factors and Hypertension Management during the COVID-19 Pandemic: Preliminary Findings from Malaysia.
COVID-19 pandemic
Malaysia
adherence
blood pressure control
health literacy
hypertension
pandemic
perspectives
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
03 09 2021
03 09 2021
Historique:
received:
04
07
2021
revised:
28
08
2021
accepted:
29
08
2021
entrez:
10
9
2021
pubmed:
11
9
2021
medline:
15
9
2021
Statut:
epublish
Résumé
The perspectives of hypertensive patients on the state of hypertension control during the ongoing pandemic restrictions have not been extensively studied in Malaysia. Therefore, this study aimed to assess the impact of socio-demographic factors, health literacy, and adherence on the overall hypertension management in a group of Malaysian hypertensive patients during the COVID-19 pandemic. An anonymous, online cross-sectional study was conducted over three months that involved a group of Malaysian adults with hypertension. A validated, self-administered 30-item questionnaire was prepared in Malay and English languages on Google Forms. The link was then distributed to participants on social media (Facebook and WhatsApp). Following survey validation, a pilot study with 30 participants who met the inclusion criteria was carried out. The total scores for health literacy, adherence, and pandemic impact on hypertension control were calculated and compared across all independent variables. In a total of 144 study participants, controlled blood pressure was reported in 77% (N = 111). There were good levels of adherence and health literacy scores but moderate levels of pandemic impact scores. The total adherence scores showed a statistically significant difference between age groups (χ
Identifiants
pubmed: 34501893
pii: ijerph18179306
doi: 10.3390/ijerph18179306
pmc: PMC8430527
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Cardiovasc Diagn Ther. 2016 Oct;6(5):439-445
pubmed: 27747167
QJM. 2013 Oct;106(10):909-14
pubmed: 23696676
J Clin Hypertens (Greenwich). 2020 Jul;22(7):1109-1119
pubmed: 32643874
J Hum Hypertens. 2013 Sep;27(9):545-51
pubmed: 23448846
Prog Cardiovasc Nurs. 2000 Summer;15(3):90-6
pubmed: 10951950
BMC Cardiovasc Disord. 2018 Oct 19;18(1):194
pubmed: 30340528
Western Pac Surveill Response J. 2021 Feb 16;12(1):46-52
pubmed: 34094624
Intern Emerg Med. 2017 Sep;12(6):765-776
pubmed: 28303441
Circulation. 2018 Jul 10;138(2):e48-e74
pubmed: 29866648
J Hypertens. 2021 Jun 1;39(6):1077-1089
pubmed: 33395152
Circ Res. 2019 Mar 29;124(7):1124-1140
pubmed: 30920917
Medicine (Baltimore). 2016 May;95(20):e3572
pubmed: 27196458
Ann Ig. 2020 May-Jun;32(3):263-273
pubmed: 32266364
Oman Med J. 2011 May;26(3):155-9
pubmed: 22043406
Rev Esp Cardiol. 2011 Jul;64(7):587-93
pubmed: 21640460
Res Social Adm Pharm. 2021 Jan;17(1):1938-1941
pubmed: 32507575
Front Public Health. 2021 May 07;9:560592
pubmed: 34026696
Patient Prefer Adherence. 2012;6:613-22
pubmed: 22969292
Res Social Adm Pharm. 2019 Feb;15(2):214-221
pubmed: 29606610
Med Clin North Am. 2009 May;93(3):753-69
pubmed: 19427503
Int J Gen Med. 2014 Jul 03;7:345-53
pubmed: 25061335
Am J Cardiol. 2012 Feb 15;109(4):570-5
pubmed: 22154320
J Hum Hypertens. 2018 Sep;32(8-9):617-624
pubmed: 29899376
Swiss Med Wkly. 2012 Oct 30;142:w13693
pubmed: 23136051
Medicina (Kaunas). 2019 May 18;55(5):
pubmed: 31109105
Nagoya J Med Sci. 2014 Aug;76(3-4):255-63
pubmed: 25741034
J Pharm Bioallied Sci. 2019 Jul-Sep;11(3):232-239
pubmed: 31555029
J Multidiscip Healthc. 2020 Jul 20;13:635-645
pubmed: 32764955
Occup Environ Med. 2020 May;77(5):281-282
pubmed: 32238444
Integr Blood Press Control. 2018 Apr 23;11:37-46
pubmed: 29720880
BMJ Open. 2019 May 19;9(5):e025869
pubmed: 31110091